Saudi Pharmaceutical Industries & Medical Appliances Corporation’s (SPIMACO) board of directors on May 4 approved forming a risk management committee, the company said in a statement to Tadawul on Thursday.
Members of the committee will serve until the end of the board’s tenth term on April 2, 2019.
SPIMACO’s board also approved forming an investment committee and has appointed its members, in addition to re-forming the nomination and bonuses’ committee for the same period.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}